Newsroom
November 9, 2017
Obesity activates a specific biological pathway in obese mice, UT Health San Antonio researchers announce Obesity does a lot more than make us hesitant to go to the beach in our swimsuits. Scientists are finding that, far from being innocent or harmless, extra weight fuels inflammation, impairs cell energy and fosters insulin resistance. All of […]
August 15, 2017
Kumar Sharma, M.D., was named chief of the Division of Nephrology and vice chair for research in the Department of Medicine.
June 20, 2017
Empagliflozin is associated with improved beta cell function in subjects with impaired fasting glucose, according to a study published online June 13 in Diabetes. Read the full story at the Doctor’s Lounge
June 10, 2017
Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the major changes he has seen in diabetes treatment in the past 50 years. Read the full story at Diabetes in Control
April 20, 2017
A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the novel approach would also allow Type 2 diabetics to stop insulin shots.
April 20, 2017
A potential cure for Type 1 diabetes looms on the horizon in San Antonio, and the novel approach would also allow Type 2 diabetics to stop insulin shots. The discovery, made at The University of Texas Health Science Center, now called UT Health San Antonio, increases the types of pancreatic cells that secrete insulin.